Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.
- DOI
- 10.1016/j.schres.2026.02.009
- Published
- 2026-02-16
- Container
- Schizophr Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.schres.2026.02.009,
title = {Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.},
author = {Uhrenholt N and Ganeshalingam A and Arnfred S and Gæde P and Pedersen AK and Larsen PV and Frystyk J and Bilenberg N.},
year = {2026},
journal = {Schizophr Res},
doi = {10.1016/j.schres.2026.02.009},
url = {https://doi.org/10.1016/j.schres.2026.02.009}
}RIS
TY - JOUR TI - Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial. AU - Uhrenholt N AU - Ganeshalingam A AU - Arnfred S AU - Gæde P AU - Pedersen AK AU - Larsen PV AU - Frystyk J AU - Bilenberg N. PY - 2026 JO - Schizophr Res DO - 10.1016/j.schres.2026.02.009 UR - https://doi.org/10.1016/j.schres.2026.02.009 ER -
APA
N, U., A, G., S, A., P, G., AK, P., PV, L., J, F., & N., B. (2026). Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.. Schizophr Res. https://doi.org/10.1016/j.schres.2026.02.009
Source records
- europe-pmc · retrieved 2026-09-27T03:45:24.335Z